Inhibition of carcinogen-induced rat mammary tumor growth and other estrogen-dependent responses by symmetrical dihalo-substituted analogs of diindolylmethane

Cancer Letters

Volumn 151, Issue 2, 2000, Pages 169-179

  McDougal, Andrew ^a   Sethi Gupta, Mona ^a   Ramamoorthy, Kavita ^a   Sun, Gulan ^a   Safe, Stephen H ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Ah receptor; Antitumorigenic; Dihalodims

Indexed keywords

4,4' DICHLORO 3,3' DIINDOLYLMETHANE; 5,5' DIBROMO 3,3' DIINDOLYLMETHANE; 5,5' DICHLORO 2,2' DIMETHYL 3,3' DIINDOLYLMETHANE; 5,5' DICHLORO 3,3' DIINDOLYLMETHANE; 5,5' DIFLUORO 3,3' DIINDOLYLMETHANE; 6,6' DICHLORO 3,3' DIINDOLYLMETHANE; CARCINOGEN; DIMETHYLBENZ[A]ANTHRACENE; ESTRADIOL; INDOLE DERIVATIVE; PROGESTERONE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST TUMOR; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; ESTROGEN ACTIVITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY MASS; LIVER WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR GROWTH; UTERUS;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARCINOGENS; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGEN ANTAGONISTS; FEMALE; HALOGENS; HUMANS; INDOLES; MAMMARY NEOPLASMS, ANIMAL; MICE; ORGAN SIZE; PEROXIDASE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PROGESTERONE; TUMOR CELLS, CULTURED; UTERUS;

ANIMALIA; MINK CELL FOCUS-FORMING VIRUS;

EID: 0034646769     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00406-1     Document Type: Article

References (34)

1. Hulka B.S., Liu E.T., Lininger R.A. Steroid hormones and risk of breast cancer. Cancer. 74:1994;1111-1124.
2. Liehr J.G. Hormone-associated cancer: mechanistic similarities between human breast cancer and estrogen-induced kidney carcinogenesis in hamsters. Environ. Health Perspect. 105:1997;565-569.
3. Li J.J., Li S.A. Estrogen carcinogenesis in hamster tissues: a critical review. Endocr. Rev. 11:1990;524-531.
4. Liehr J.G. Genotoxic effects of estrogens. Mutat. Res. 238:1990;269-276.
5. Bradlow H.L., Hershcopf R.J., Martucci C.P., Fishman J. Estradiol 16α-hydroxylation in the mouse correlate with mammary tumor incidence and presence of murine mammary tumor virus: a possible model for the hormonal etiology of breast cancer in humans. Proc. Natl. Acad. Sci. USA. 82:1985;6295-6299.
6. Swaneck G.E., Fishman J. Covalent binding of the endogenouse estrogen 16α-hydroxyestrone to estradiol receptor in human breast cancer cells: characterization and intranuclear localization. Proc. Natl. Acad. Sci. USA. 85:1988;7831-7835.
7. Jordan V.C. Biochemical pharmacology of antiestrogen action. Pharmacol. Rev. 36:1984;245-270.
8. Jordan V.C. A current view of tamoxifen for the treatment and prevention of breast cancer. Br. J. Pharmacol. 110:1993;507-517.
9. Brodie A.M., Santen R.J. Aromatase and its inhibitors in breast cancer treatment - overview and perspective. Breast Cancer Res. Treat. 30:1994;1-6.
10. Colston K.W., Chander S.K., Mackay A.G., Coombes R.C. Effects of synthetic Vitamin D analogues on breast cancer cell proliferation in vivo and in vitro. Biochem. Pharmacol. 44:1992;693-702.
11. Hong W.K., Itri L.M. Retinoids and human cancer. Sporn M.B., Roberts A.B., Goodman D.S. The Retinoids: Biology, Chemistry, and Medicine. 1994;597-630 Raven Press, New York.
12. Fraker L.D., Halter S.A., Forbes J.T. Growth inhibition by retinol of a human breast carcinoma cell line in vitro and in athymic mice. Cancer Res. 44:1984;5757-5763.
13. Safe S. Modulation of gene expression and endocrine response pathways by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds. Pharmacol. Therap. 67:1995;247-281.
14. Zacharewski T., Safe S. Antiestrogenic activity of TCDD and related compounds. Korach K.S. Reproductive and Developmental Toxicology. 1998;431-448 Marcel Dekker, New York.
15. Safe S. Interactions between hormone and chemicals in breast cancer. Annu. Rev. Pharmacol. Toxicol. 38:1998;121-158.
16. Kociba R.J., Keyes D.G., Beger J.E., Carreon R.M., Wade C.E., Dittenber D.A., Kalnins R.P., Frauson L.E., Park C.L. Results of a 2-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rats. Toxicol. Appl. Pharmacol. 46:1978;279-303.
17. Holcomb M., Safe S. Inhibition of 7,12-dimethylbenzanthracene-induced rat mammary tumor growth by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cancer Lett. 82:1994;43-47.
18. Tritscher A.M., Clark G.C., Sewall C., Sills R.C., Maronpot R., Lucier G.W. Persistence of TCDD-induced hepatic cell proliferation and growth of enzyme altered foci after chronic exposure followed by cessation of treatment in DEN initiated female rats. Carcinogenesis. 16:1995;2807-2811.
19. Gierthy J.F., Bennett J.A., Bradley L.M., Cutler D.S. Correlation of in vitro and in vivo growth suppression of MCF-7 human breast cancer by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cancer Res. 53:1993;3149-3153.
20. McDougal A., Wilson C., Safe S. Inhibition of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumor growth by aryl hydrocarbon receptor agonists. Cancer Lett. 120:1997;53-63.
21. Chen I., McDougal A., Wang F., Safe S. Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane. Carcinogenesis. 19:1998;1631-1639.
22. Safe S., Qin C., McDougal A. Development of selective aryl hydrocarbon receptor modulators (SARMs) for treatment of breast cancer. Exp. Opin. Invest. Drugs. 8:1999;1385-1396.
23. Lyttle C.R., DeSombre E.R. Uterine peroxidase as a marker for estrogen action. Proc. Natl. Acad. Sci. USA. 74:1977;3162-3166.
24. Moore M., Wang X., Lu Y.-F., Wormke M., Craig A., Gerlach J., Burghardt R., Safe S. Benzo[a]pyrene resistant (BaPR) human breast cancer cells: a unique aryl hydrocarbon (Ah)-non-responsive clone. J. Biol. Chem. 269:1994;11751-11759.
25. Astroff B., Safe S. Comparative antiestrogenic activities of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 6-methyl-1,3,8- trichlorodibenzofuran in the female rat. Toxicol. Appl. Pharmacol. 95:1988;435-443.
26. Dickerson R., Howie-Keller L., Safe S. Alkyl polychlorinated dibenzofurans and related compounds as antiestrogens in the female rat uterus: structure-activity studies. Toxicol. Appl. Pharmacol. 135:1995;287-298.
27. Wattenberg L.W., Loub W.D. Inhibition of aromatic hydrocarbon-induced neoplasia by naturally occurring indoles. Cancer Res. 38:1978;1410-1413.
28. Tanaka T., Mori Y., Morishita Y., Hara A., Ohno T., Kojima T., Mori H. Inhibitory effect of sinigrin and indole-3-carbinol in diethylnitrosamine-induced hepatocarcinogenesis in male ACI/N rats. Carcinogenesis. 11:1990;1403-1406.
29. Nixon J.E., Hendricks J.D., Pawlowski N.E., Pereira C.B., Sinnhuber R.O., Bailey G.S. Inhibition of aflatoxin B1 carcinogenesis in rainbow trout by flavone and indole compounds. Carcinogenesis. 5:1984;615-619.
30. Kim D.J., Lee K.K., Han B.S., Ahn B., Bae J.H., Jang J.J. Biphasic modifying effect on indole-3-carbinol on diethylnitrosamine-induced preneoplastic glutathione S-transferase placental form-positive liver cell foci in Sprague-Dawley rats. Jpn. J. Cancer Res. 85:1994;578-583.
31. Morse M.A., LaGreca S.D., Amin S.G., Chung F.L. Effects of indole-3-carbinol on lung tumorigenesis and DNA methylation induced by 4-(methylnitrosamino)-1-(3-pyridl)-1-butanone (NNK) and on the metabolism and disposition of NNK in A/J mice. Cancer Res. 50:1990;1613-1617.
32. Kojima T., Tanaka T., Mori H. Chemoprevention of spontaneous endometrial cancer in female Donryu rats by dietary indol-3-carbinol. Cancer Res. 54:1994;1446-1449.
33. Grubbs C.J., Steele V.E., Casebolt T., Juliana M.M., Eto I., Whitaker L.M., Dragnev K.H., Kelloff G.J., Lubet R.L. Chemoprevention of chemically-induced mammary carcinogenesis by indole-3-carbinol. Anticancer Res. 15:1995;709-716.
34. Bjeldanes L.F., Kim J.Y., Grose K.R., Bartholomew J.C., Bradfield C.A. Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo - comparisons with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Proc. Natl. Acad. Sci. USA. 88:1991;9543-9547.